160 related articles for article (PubMed ID: 37285035)
1. Less Irradiation to Lymphocyte-Related Organs Reduced the Risk of G4 Lymphopenia in Esophageal Cancer: Re-Analysis of Prospective Trials.
Tseng I; Li F; Ai D; Chen Y; Xu Y; Yu L; Hao S; Zhu H; Deng J; Liu Q; Pan F; Su F; Zhao K
Oncologist; 2023 Aug; 28(8):e645-e652. PubMed ID: 37285035
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs.
Tseng I; Ai D; Chen Y; Zhu H; Li F; Xu Y; Yu L; Liu Q; Deng J; Hao S; Zhu Z; Zhao W; Fan M; Li L; Su F; Zhao K
Radiat Oncol; 2023 Oct; 18(1):172. PubMed ID: 37858121
[TBL] [Abstract][Full Text] [Related]
3. Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes.
Xu H; Lin M; Hu Y; Zhang L; Li Q; Zhu J; Wang S; Xi M
Oncologist; 2021 Mar; 26(3):e425-e434. PubMed ID: 32960471
[TBL] [Abstract][Full Text] [Related]
4. Spleen Dose-Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer.
Saito T; Toya R; Yoshida N; Shono T; Matsuyama T; Ninomura S; Watakabe T; Sasaki Y; Baba H; Oya N
In Vivo; 2018; 32(6):1519-1525. PubMed ID: 30348711
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow dosimetric analysis of lymphopenia in patients with esophageal squamous cell carcinoma treated with chemoradiotherapy.
Wang Q; Qiu Q; Zhang Z; Zhang J; Yang G; Liu C; Li B
Cancer Med; 2021 Sep; 10(17):5847-5858. PubMed ID: 34363346
[TBL] [Abstract][Full Text] [Related]
6. Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia and affect prognosis in patients with locally advanced esophageal cancer receiving definitive concurrent chemoradiotherapy.
Chen X; Tian X; Zhang X; Deng Q; Wang M; Zhou X; Xu Y; Zhou L; Zou B; Liu Y; Ao R; Lu Y; Gong Y
Thorac Cancer; 2023 Sep; 14(27):2735-2744. PubMed ID: 37519061
[TBL] [Abstract][Full Text] [Related]
7. Association Between Lymphopenia and Survival Outcomes in Esophageal Carcinoma Patients Receiving Combined Immunotherapy and Chemoradiotherapy.
Cheng X; Chen B; Wang S; Zhang J; Zhu J; Liu M; Liu S; Xi M
Oncologist; 2023 Aug; 28(8):e606-e616. PubMed ID: 37061835
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte Nadir and Esophageal Cancer Survival Outcomes After Chemoradiation Therapy.
Davuluri R; Jiang W; Fang P; Xu C; Komaki R; Gomez DR; Welsh J; Cox JD; Crane CH; Hsu CC; Lin SH
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):128-135. PubMed ID: 28816138
[TBL] [Abstract][Full Text] [Related]
9. Platelet-to-albumin ratio and radiation-induced lymphopenia-prognostic biomarker for carcinoma esophagus.
Ghosh A; Dagar A; Bharat RP; Raj J; Shah D; Sharma J; Kumar A; Patil PA; Sharma A; Sharma D; Mallick S
J Egypt Natl Canc Inst; 2024 Feb; 36(1):4. PubMed ID: 38311646
[TBL] [Abstract][Full Text] [Related]
10. Cardiac radiation dose predicts survival in esophageal squamous cell carcinoma treated by definitive concurrent chemotherapy and intensity modulated radiotherapy.
Pao TH; Chang WL; Chiang NJ; Chang JS; Lin CY; Lai WW; Tseng YL; Yen YT; Chung TJ; Lin FC
Radiat Oncol; 2020 Sep; 15(1):221. PubMed ID: 32962730
[TBL] [Abstract][Full Text] [Related]
11. The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy.
Xu C; Jin JY; Zhang M; Liu A; Wang J; Mohan R; Kong FS; Lin SH
Radiother Oncol; 2020 May; 146():180-186. PubMed ID: 32182504
[TBL] [Abstract][Full Text] [Related]
12. Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma.
Qiu J; Lin H; Ke D; Yu Y; Xu J; Qiu H; Zheng Q; Li H; Zheng H; Liu L; Wang Z; Yao Q; Li J
Front Immunol; 2023; 14():1066255. PubMed ID: 37223094
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced lymphopenia correlates with survival in nasopharyngeal carcinoma: impact of treatment modality and the baseline lymphocyte count.
Xie X; Gong S; Jin H; Yang P; Xu T; Cai Y; Guo C; Zhang R; Lou F; Yang W; Wang H
Radiat Oncol; 2020 Mar; 15(1):65. PubMed ID: 32169088
[TBL] [Abstract][Full Text] [Related]
14. Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy.
Zhou XL; Zhu WG; Zhu ZJ; Wang WW; Deng X; Tao WJ; Ji FZ; Tong YS
Oncologist; 2019 Aug; 24(8):e677-e686. PubMed ID: 31040254
[TBL] [Abstract][Full Text] [Related]
15. The impact of bone marrow irradiation dose on acute haematologic toxicity in cervical cancer patients treated with concurrent chemoradiotherapy.
Chen M; Wang D; Bao Z; Yi Z; Mei Z; Sun S; Xiang Q; Yang C; Yang H; Qiu H; Xie C
Radiat Oncol; 2023 Apr; 18(1):66. PubMed ID: 37031167
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil-to-Lymphocyte Ratio After Definitive Concurrent Chemoradiotherapy Predicts Survival in Patients With Esophageal Squamous Cell Carcinoma.
Koh HK; Park Y; Koo T; Park HJ; Lee MY; Chang AR; Hong S; Bae H
In Vivo; 2021; 35(2):1133-1139. PubMed ID: 33622911
[TBL] [Abstract][Full Text] [Related]
17. Combined modality therapy for patients with esophageal squamous cell carcinoma: Radiation dose and survival analyses.
Shueng PW; Huang CC; Liu YM; Wu YH; Huang PI; Yen SH; Lin KH; Hsu CX
Thorac Cancer; 2023 Jan; 14(2):143-148. PubMed ID: 36351568
[TBL] [Abstract][Full Text] [Related]
18. The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy.
Deng W; Xu C; Liu A; van Rossum PSN; Deng W; Liao Z; Koong AC; Mohan R; Lin SH
Radiother Oncol; 2019 Apr; 133():9-15. PubMed ID: 30935587
[TBL] [Abstract][Full Text] [Related]
19. Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy.
Jin Z; Sun X; Zhou C; Yang H; Zhou S
Neoplasia; 2024 Feb; 48():100969. PubMed ID: 38199173
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic analysis of definitive radiotherapy for early esophageal carcinoma(T1-2N0M0): a multi-center retrospective study of Jing-Jin-ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group].
Lu N; Wang X; Li C; Wang L; Chen JQ; Zhang WC; Wang XM; Ge XL; Shen WB; Hu MM; Yuan QQ; Xu YG; Hao CL; Zhou ZG; Qie S; Xiao ZF; Zhu SC; Han C; Qiao XY; Pang QS; Wang P; Zhao YD; Sun XC; Zhang KX; Li L; Li GF; Liu ML; Wang YD
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):139-144. PubMed ID: 32135649
[No Abstract] [Full Text] [Related]
[Next] [New Search]
